NEA 14 GP, LTD's Net Worth

$167 Million

Who is NEA 14 GP, LTD?

NEA 14 GP, LTD has an estimated net worth of $167 Million. This is based on reported shares across multiple companies, which include Strongbridge Biopharma plc, INTERLEUKIN GENETICS INC, MULESOFT, INC, Oyster Point Pharma, Inc., APPIAN CORP, Mersana Therapeutics, Inc., Adaptimmune Therapeutics PLC, Loxo Oncology, Inc., CHAMPIONS ONCOLOGY, INC., Surface Oncology, Inc., Galera Therapeutics, Inc., Tracon Pharmaceuticals, Inc., SYNLOGIC, INC., Cerecor Inc., IMARA Inc., Casper Sleep Inc., and ZeroFox Holdings, Inc..

SEC CIK

NEA 14 GP, LTD's CIK is 0001551532

Past Insider Trading and Trends

2018 was NEA 14 GP, LTD's most active year for acquiring shares with 30 total transactions. NEA 14 GP, LTD's most active month to acquire stocks was the month of February. 2022 was NEA 14 GP, LTD's most active year for disposing of shares, totalling 19 transactions. NEA 14 GP, LTD's most active month to dispose stocks was the month of December. 2017 saw NEA 14 GP, LTD paying a total of $24,009,000.00 for 58,948,211 shares, this is the most they've acquired in one year. In 2017 NEA 14 GP, LTD cashed out on 70,082,988 shares for a total of $66,073,750.64, their largest year based on trade value.